Search clinical trials for: Imatinib Mesylate
Total 2429 results
-
University of Milano BicoccaCompletedChronic Myeloid LeukemiaCanada, Germany, Israel, Italy, Spain
-
Novartis PharmaceuticalsCompletedPulmonary Arterial HypertensionUnited States, Switzerland, Germany, Belgium, Spain, United Kingdom, Italy, Korea, Republic of, Netherlands, Canada, Sweden, Austria, Japan, France
-
European Organisation for Research and Treatment...CompletedSarcomaFrance, Belgium, Netherlands, United Kingdom
-
Sarcoma Alliance for Research through CollaborationCompletedDermatofibrosarcoma ProtuberansUnited States
-
Dr. Jurjan AmanExvastat Ltd.; Simbec-Orion Group; KABS laboratoriesTerminatedCovid19 | Endothelial Dysfunction | Acute Respiratory Distress Syndrome | ARDS | Pulmonary EdemaNetherlands
-
Duke UniversityNovartis PharmaceuticalsCompletedGlioblastoma | GliosarcomaUnited States
-
M.D. Anderson Cancer CenterJohnson & Johnson Pharmaceutical Research & Development, L.L.C.CompletedLeukemia, Myeloid, ChronicUnited States
-
Novartis PharmaceuticalsActive, not recruitingGIST and CMLChina, Turkey, Singapore, France, Switzerland, Thailand, United States, Romania, Hong Kong, Finland, United Kingdom
-
Novartis PharmaceuticalsCompletedPhiladelphia Chromosome Positive CMLUnited States, Germany, Italy, France
-
National Cancer Institute (NCI)Cancer and Leukemia Group BCompletedRecurrent Small Cell Lung CancerUnited States
-
Sarcoma Alliance for Research through CollaborationNovartis PharmaceuticalsTerminatedGastrointestinal Stromal TumorsUnited States
-
NovartisCompleted
-
Lawson Health Research InstituteNovartis PharmaceuticalsTerminated
-
Poitiers University HospitalCompleted
-
Fred Hutchinson Cancer CenterCompleted
-
Novartis PharmaceuticalsCompletedChronic Myelomonocytic Leukemia | Hypereosinophilic Syndrome | Systemic Mastocytosis | DermatofibrosarcomaAustralia
-
Novartis PharmaceuticalsTerminatedHypereosinophilic SyndromeBelgium
-
Centre Oscar LambretCompleted
-
University of AarhusCompletedNephrogenic Systemic FibrosisDenmark
-
Novartis PharmaceuticalsCompletedGastrointestinal Stromal TumorsSaudi Arabia, Taiwan, Turkey, Egypt, Thailand, Russian Federation, South Africa, Lebanon, India, Tunisia, Algeria, Jordan
-
National Cancer Institute (NCI)TerminatedBrain and Central Nervous System TumorsUnited States
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI); Beth Israel Deaconess Medical CenterCompleted
-
National Cancer Institute (NCI)CompletedSclerotic Graft Versus Host Disease | Imatinib MesylateUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...National Cancer Institute (NCI)CompletedBrain and Central Nervous System TumorsUnited States
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedLeukemiaUnited States, Canada, Puerto Rico, Australia, Netherlands, New Zealand, Switzerland
-
European Organisation for Research and Treatment...Terminated
-
M.D. Anderson Cancer CenterNovartisCompletedAcute Myelogenous Leukemia | Chronic Myelogenous Leukemia | Agnogenic Myeloid MetaplasiaUnited States
-
Baylor College of MedicineRecruitingChronic Myeloid Leukemia | Chronic Myeloid Leukemia, BCR/ABL-Positive, in Remission | Chronic Myeloid Leukemia in RemissionUnited States
-
Novartis PharmaceuticalsTerminatedLeukemia, Myeloid, Chronic PhaseUnited States, Argentina, Italy, Canada, Australia, Brazil
-
Jonsson Comprehensive Cancer CenterNational Cancer Institute (NCI)Unknown
-
University of California, San FranciscoJuvenile Diabetes Research FoundationCompletedType 1 Diabetes Mellitus | Diabetes Mellitus, Type I | Insulin-Dependent Diabetes Mellitus 1 | Diabetes Mellitus, Insulin-Dependent, 1 | IDDMUnited States, Australia
-
Technical University of MunichCompletedGastrointestinal Stromal TumorGermany, Austria
-
M.D. Anderson Cancer CenterCompletedChronic Myelogenous LeukemiaUnited States
-
University of PittsburghNovartisCompleted
-
Goethe UniversityCompletedALL, Recurrent, AdultGermany
-
Goethe UniversityRecruiting
-
M.D. Anderson Cancer CenterNovartis PharmaceuticalsTerminatedMyelogenous Leukemia, Chronic, Chronic PhaseUnited States
-
Brigham and Women's HospitalNational Heart, Lung, and Blood Institute (NHLBI); Baim Institute for Clinical...Completed
-
M.D. Anderson Cancer CenterAbiogen PharmaTerminatedChronic Myelogenous LeukemiaUnited States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)Completed
-
Herbert HurwitzNational Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
OHSU Knight Cancer InstituteNational Cancer Institute (NCI)Completed
-
M.D. Anderson Cancer CenterBreakThrough TherapeuticsCompletedChronic Myeloid Leukemia | Minimal Residual DiseaseUnited States
-
Oncology Specialists, S.C.CompletedProstate CancerUnited States
-
National Cancer Institute (NCI)CompletedPrimary Myelofibrosis | Polycythemia Vera | Essential Thrombocythemia | Chronic Myelomonocytic LeukemiaUnited States
-
National Cancer Institute (NCI)CompletedStage IV Ovarian Epithelial Cancer | Primary Peritoneal Cavity Cancer | Recurrent Ovarian Epithelial Cancer | Stage III Ovarian Epithelial CancerUnited States
-
National Cancer Institute (NCI)CompletedMale Breast Cancer | Stage IV Breast Cancer | Recurrent Breast CancerUnited States
-
Fox Chase Cancer CenterNational Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
National Cancer Institute (NCI)Gynecologic Oncology GroupCompletedUterine Carcinosarcoma | Recurrent Uterine SarcomaUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Melanoma | Stage IV Melanoma | Stage IIIA Melanoma | Stage IIIB Melanoma | Stage IIIC Melanoma | Acral Lentiginous Malignant MelanomaUnited States